The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
- PMID: 7552725
- DOI: 10.1038/nsb0895-637
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
Abstract
Aspirin exerts its anti-inflammatory effects through selective acetylation of serine 530 on prostaglandin H2 synthase (PGHS). Here we present the 3.4 A resolution X-ray crystal structure of PGHS isoform-1 inactivated by the potent aspirin analogue 2-bromoacetoxy-benzoic acid. Acetylation by this analogue abolishes cyclooxygenase activity by steric blockage of the active-site channel and not through a large conformational change. We observe two rotameric states of the acetyl-serine side chain which block the channel to different extents, a result which may explain the dissimilar effects of aspirin on the two PGHS isoforms. We also observe the product salicylic acid binding at a site consistent with its antagonistic effect on aspirin activity.
Comment in
-
Aspirin and inflammation.Nat Struct Biol. 1995 Aug;2(8):605-6. doi: 10.1038/nsb0895-605. Nat Struct Biol. 1995. PMID: 7552717 No abstract available.
Similar articles
-
Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.ChemMedChem. 2009 Jun;4(6):939-45. doi: 10.1002/cmdc.200800438. ChemMedChem. 2009. PMID: 19301318
-
Aspirin--now we can see it.Nat Med. 1995 Sep;1(9):882-3. doi: 10.1038/nm0995-882. Nat Med. 1995. PMID: 7585209 Review. No abstract available.
-
Aspirin and inflammation.Nat Struct Biol. 1995 Aug;2(8):605-6. doi: 10.1038/nsb0895-605. Nat Struct Biol. 1995. PMID: 7552717 No abstract available.
-
O-acetylsalicylhydroxamic acid, a novel acetylating inhibitor of prostaglandin H2 synthase: structural and functional characterization of enzyme-inhibitor interactions.Mol Pharmacol. 2001 Dec;60(6):1407-13. doi: 10.1124/mol.60.6.1407. Mol Pharmacol. 2001. PMID: 11723249
-
Cox-2-selective inhibitors: the new super aspirins.Mol Pharmacol. 1999 Apr;55(4):625-31. Mol Pharmacol. 1999. PMID: 10101019 Review. No abstract available.
Cited by
-
The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).Adv Pharmacol. 2023;97:423-444. doi: 10.1016/bs.apha.2022.12.002. Epub 2023 Jan 10. Adv Pharmacol. 2023. PMID: 37236766 Free PMC article.
-
Synthesis and Significance of Arachidonic Acid, a Substrate for Cyclooxygenases, Lipoxygenases, and Cytochrome P450 Pathways in the Tumorigenesis of Glioblastoma Multiforme, Including a Pan-Cancer Comparative Analysis.Cancers (Basel). 2023 Feb 2;15(3):946. doi: 10.3390/cancers15030946. Cancers (Basel). 2023. PMID: 36765904 Free PMC article. Review.
-
Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition.Molecules. 2022 Oct 14;27(20):6905. doi: 10.3390/molecules27206905. Molecules. 2022. PMID: 36296501 Free PMC article.
-
Determinants of Urinary Incontinence and Subtypes Among the Elderly in Nursing Homes.Front Public Health. 2021 Dec 6;9:788642. doi: 10.3389/fpubh.2021.788642. eCollection 2021. Front Public Health. 2021. PMID: 34938714 Free PMC article.
-
Acetylated Thioredoxin Reductase 1 Resists Oxidative Inactivation.Front Chem. 2021 Sep 15;9:747236. doi: 10.3389/fchem.2021.747236. eCollection 2021. Front Chem. 2021. PMID: 34604175 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases